Currently Used Biologic Agents in the Management of Behcet’s Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|16|1976-1985

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.16, 2015-05, pp. : 1976-1985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Targets of Currently Used Antibacterial Agents: Lessons for Drug Discovery

By  

Current Pharmaceutical Design, Vol. 13, Iss. 30, 2007-10 ,pp. : 3140-3154

Bentham Science Publishers

Access to resources Recommend Favorite

Depression as a Comorbidity in Behcet's Syndrome

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 1041-1048

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Actions and Metabolism of Currently Used Pharmacological Agents for the Treatment of Congestive Heart Failure

By  

Current Drug Metabolism, Vol. 10, Iss. 3, 2009-03 ,pp. : 206-219

Bentham Science Publishers

Access to resources Recommend Favorite

The Pharmacokinetics of Biologic Agents

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 1, 2010-03 ,pp. : 3-7

Bentham Science Publishers

Access to resources Recommend Favorite

Purification of Paraoxonase Enzyme From the Sera of Patients with Behcet’s Disease and Analyzing the Effects of the Drugs Containing Imuran (Azathioprine), Prednisolone (Methylprednisolone) and Colchium (Colchicine)

By  

Drug Metabolism Letters, Vol. 8, Iss. 1, 2014-06 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite